Here are some of the latest health and medical news
developments, compiled by the editors of HealthDay:
Heart Attack Grill Diner May Have Suffered Heart Attack
The Heart Attack Grill in Las Vegas seemed to live up to its
name after a customer suffered what may have been a heart
Amateur video shows paramedics wheeling a man out of the
restaurant on Saturday evening. Restaurant workers said it appeared
the man had a heart attack, the
Associated Press reported.
When a waitress told him a customer eating a Triple Bypass
burger was sweating and shaking, grill owner Jon Basso thought it
was a joke. Basso told a TV station that he heard the man is
Details about the man's name and his medical condition weren't
Consumer Guide Reveals Toxicity of Vehicle Interiors
The Honda Civic, Toyota Prius and Honda CR-Z have the least
toxic interiors, while the Mitsubishi Outlander has the most toxic
passenger compartment, according to a new report by the
Michigan-based Ecology Center.
The nonprofit group's guide notes that vehicle makers are
reducing their use of toxic chemicals, and the industry leaders
have eliminated hazardous flame retardants and PVC (polyvinyl
USA Today reported.
The Ecology Center's fourth consumer guide on the topic says
that 60 percent of new vehicle interiors are made without
brominated flame retardants and 17 percent are PVC-free.
Chemicals used in vehicle interiors have been associated with
health problems such as allergies, impaired learning and liver
USA Today reported.
"Vehicle interiors contain a unique cocktail of hundreds of toxic chemicals that off-gas in small, confined spaces," said Jeff Gearhart, research director at the Ecology Center. "Since these chemicals are not regulated, consumers have no way of knowing the dangers they face. Our testing is intended to expose those dangers and encourage manufacturers to use safer alternatives."
Traces of Lead Found in 400 Lipsticks: FDA Analysis
In news that is sure to dampen the spirit of romance on
Valentine's Day, an analysis from the U.S. Food and Drug
Administration has found that 400 of the most popular lipsticks in
the United States contain traces of lead.
The lipsticks involved are made by major cosmetic firms, and
include such widely known brands as L'Oreal, Maybelline and Cover
Girl, according to the analysis. The results confirm an earlier
review, but on a greater scale and at higher lead levels, the
Washington Post reported.
The Campaign for Safe Cosmetics, a consumer group, has been
pushing for limits on lead levels in lipsticks for years but the
FDA has balked, saying the levels detected do not pose a safety
risk to women, the
"Lipstick, as a product intended for topical use with limited absorption, is ingested only in very small quantities," the agency said on its website. "The lead levels we found are within the limits recommended by other public health authorities for lead in cosmetics, including lipstick."
Products sampled in 2010 had average concentrations of 1.11
parts per million, close to the average of 1.07 parts per million
in a smaller survey the FDA conducted in 2007, according to the
Satisfied Patients Aren't Always Healthier: Study
A satisfied patient isn't necessarily a healthier patient,
according to a new study.
The research included almost 52,000 Americans who were followed
for an average of 3 1/2 years. They were asked to rate their
satisfaction with the care they received from their doctors and
their health outcomes were then tracked by the University of
California, Davis researchers, the
Los Angeles Times reported.
Compared with patients who were least-satisfied with their
healthcare, those who were most satisfied used more prescription
drugs, made more doctor's office visits, and were more likely to
have one or more hospital stays, according to the study published
online Monday in the journal
Archives of Internal Medicine.
This was despite the fact that patients most satisfied with
their healthcare were in better overall physical and mental health,
The study also found that the most satisfied patients were more
likely to die within a few years than those who were least
Drug Company Warns About Fake Avastin
Counterfeit vials of the cancer drug Avastin are being
distributed in the United States, according to the maker of the
medicine used to treat colon, lung, kidney and brain cancer.
The fake products do not contain the key ingredient in Avastin,
warned Roche's Genentech unit, the
Associated Press reported.
Drugs labeled with the lot numbers B86017, B6011 and B6010 are
believed to be fake, the company said. The counterfeit products do
not have Genentech printed on the packaging.
Doctors who believe they have received counterfeit Avastin
should contact the U.S. Food and Drug Administration or Roche, the
Artificial Hip Rejected by FDA Sold in Other Countries
Johnson & Johnson continued to market an artificial hip in
other countries after the Food and Drug Administration in 2009
denied approval for the product to be sold in the United States
based on a review of company safety studies.
The DePuy orthopedic division of Johnson & Johnson also
continued to sell a similar model of articular surface replacement
(ARS) device in the United States after the FDA rejected the other
The New York Times reported.
Both models had an all-metal hip socket cup that experts say was
faulty in design. Both models were recalled in August 2010 amid
reports of high rates of premature failure.
The two implants were on the market for about eight years and
used in about 93,000 patients worldwide, about one-third of them in
the U.S., according to
Research Reveals How Aspirin May Slow Cancer's Spread
New research reveals how aspirin and other anti-inflammatory
medications might slow the spread of cancer.
Although this effect has been known by scientists, the
biological mechanisms were not understood,
Fox News reported Tuesday. The breakthrough research,
reported in the Feb. 14 issue of
Cancer Cell, was conducted by experts at the Peter MacCallum Cancer Centre in Melbourne, Australia.
Study co-author Tara Karnezis told
Fox News that tumors secret proteins and compounds called
growth factors, which draw blood and lymphatic vessels to the tumor
that enable its spread.
"But a group of drugs reverse the widening of the supply line and make it hard for the tumor to spread -- at the end of the day that's what kills people," Karnezis told Fox News. "This discovery unlocks a range of potentially powerful new therapies to target this pathway in lymphatic vessels, effectively tightening a tumor's supply lines and restricting the transport of cancer cells to the rest of the body."